Pancreatic Disorders Fecal Microbiome Signatures May Predict Pancreatic Ductal Adenocarcinoma By Colby Stong
Pancreatic Disorders Drug Funding Reimbursement Associated With Improved Survival in Advanced Pancreatic Cancer By Colby Stong
Pancreatic Disorders PRECEDE Consortium Develops Strategy for Improving Early Detection of Pancreatic Cancer By Colby Stong
Pancreatic Disorders Peer Support Decreased Psychological Burden in the Pancreatobiliary Cancer Setting By Stephan Cho
Pancreatic Disorders SIRT5 Activation Shows Promise for Pancreatic Ductal Adenocarcinoma By Brandon May
Pancreatic Disorders Pancreatic Cancer May Be Associated With New-Onset Diabetes in High-Risk Patients By Jessica Nye, PhD
Pancreatic Disorders Welireg Approved for Cancers Associated With Von Hippel-Lindau Disease By Brian Park, PharmD
Pancreatic Disorders EUS-FNB Without ROSE Not Inferior to EUS-FNB With ROSE for Detecting Solid Pancreatic Lesions By Colby Stong
Pancreatic Disorders Adverse Effects Associated With Ionizing Radiation in Necrotizing Pancreatitis By Rita Aghjayan
Pancreatic Disorders Treating Gastroenteropancreatic Neuroendocrine Tumors With PRRT By Rita Aghjayan
Pancreatic Disorders Olaparib Shows Potential Efficacy in Subset of Patients With Platinum-Sensitive PDAC With DDR By Brandon May
Pancreatic Disorders Advances and Possible Personalized Medicine in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia By Jessica Nye, PhD
Pancreatic Disorders Rosiglitazone May Have Potential for Targeting Pancreatic Cancer Stem Cells By Colby Stong
Pancreatic Disorders Relative Safety of Combined vs Separate Division of Splenic Vein in Distal Pancreatectomy By Emily Pond
Pancreatic neoplasms Contrast-Enhanced vs Conventional Endoscopic Ultrasound for Diagnosis of Pancreatic Lesions By Brandon May
Pancreatic neoplasms Vitamin D and Pancreatic Cancer: is There a Link? By C. Andrew Kistler, MD, PharmD